who owns glp 1 GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Overview of GLP-1s
Description
Catalent advantage: Vitamin D3 Gummies delivering 50 mcg (2,000 IU) Cholecalciferol per serving Consumer-preferred gummy format designed for daily adherence Supports bone, muscle, and immune health needs Trusted development expertise tailored to evolving wellness trends The opportunity isn't just supplementationit's helping consumers maintain foundational health through convenient formats that fit seamlessly into everyday routines
Results sent to your provider
The Trump administrations latest agreements with two major drugmakers to lower the cost of expensive weight loss and diabetes drugs, known as GLP-1s, are lik
Used together in a compounded formulation, this pairing can elevate results for patients on a wellness or weight loss journey
Eriomin is a natural ingredient clinically shown to boost GLP-1 levels, supporting healthy blood glucose and body weight management.
